Modeling gene-environment interactions in Parkinson’s Disease: Helicobacter pylori induces CD8 T cell associated motor phenotype in PINK1-/- mice 9116
Abstract Description Parkinson’s disease (PD) is a neurodegenerative disorder with progressive loss of dopaminergic neurons in substantia nigra and motor dysfunction. Genetic risk factors, environmental triggers, and dysregulated immune response have been implicated in PD. Here, we aim to study PD- associated gene - PINK1 and pathogen-Helicobacter (H.) pylori in the PD development and immune autoreactivity. We established H. pylori infection in Pink1 -/- mice and wild-type littermate controls. At two months post-infection mice underwent behavioral tests, and the stomach, the brain and the spleen were harvested. We developed in vitro assays of H.pylori induced priming of autoreactive CD8 T cells and suppression by regulatory T cells (T reg). H.pylori infected Pink1-/- mice developed a PD-like motor-behavioral dysfunction that was abrogated by CD8 cells depletion prior to infection. Motor-behaviural phenotype in infected KO mice strongly correlated with the yield of MitAg+ CD8 cells and CD8 T cell brain infiltration. H.pylori infection in vivo and in vitro altered T reg FoxP3 expression. The absence of PINK1 in dendritic cells exposed to H.pylori triggered robust priming of autoreactive 2C T cells, that can be suppressed by the WT, but poorly by the PINK1-deficient T regs. Using a model that integrates PINK1 gene and a PD-relevant pathogen we recapitulated the major features of the complex PD pathophysiology and were able to demonstrate an immune autoreactivity underlying the phenotype. Funding Sources This study was funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and the Aligning Science Across Parkinson’s (ASAP) initiative. MJFF administers the grant ASAP 000525 on behalf of ASAP and itself. Topic Categories Neuroimmunology (NEUR)
Authors
- Hicham Bessaiah (ORCID: https://orcid.org/0000-0001-7333-2581)
- Jacqueline Sung (ORCID: https://orcid.org/0000-0002-6078-5140)
- Christina Gavino (ORCID: https://orcid.org/0000-0002-3487-334X)
- Samantha Gruenheid (ORCID: https://orcid.org/0000-0002-0908-6715)
- Pierre Thibault (ORCID: https://orcid.org/0000-0001-5993-0331)
- Alexandra Kazanova (ORCID: https://orcid.org/0000-0003-4850-9845)
- Nathalia Oliveira
- Joël Lanoix (ORCID: https://orcid.org/0000-0001-7073-9298)
- Morgane Brouillard-Galipeau (ORCID: https://orcid.org/0000-0002-9649-3852)
- Wilson H. Miller (ORCID: https://orcid.org/0000-0002-7408-1574)
- Sherilyn Junelle Recinto (ORCID: https://orcid.org/0000-0001-9632-1201)
- Nathalie Labrecque (ORCID: https://orcid.org/0000-0001-7563-1542)
- Lucía Guerra-Menéndez (ORCID: https://orcid.org/0000-0001-8724-6385)
- Jo Anne Stratton (ORCID: https://orcid.org/0000-0002-1205-1353)
- Heidi M. McBride (ORCID: https://orcid.org/0000-0003-4666-2280)
- Moustafa Nouh Elemeery (ORCID: https://orcid.org/0000-0001-6507-7920)
- Adam MacDonald (ORCID: https://orcid.org/0000-0002-6470-1186)
- Michel Desjardins (ORCID: https://orcid.org/0000-0002-5684-5980)
- Lindsay Burns (ORCID: https://orcid.org/0000-0003-4514-254X)
Institutions
- Montreal Clinical Research Institute (CA)
- McGill University (CA)
- Université de Montréal (CA)
Publication Details
- Journal
- The Journal of Immunology
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1093/jimmun/vkaf283.2563
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00